NO20001403L - Substituerte kromanderivater - Google Patents
Substituerte kromanderivaterInfo
- Publication number
- NO20001403L NO20001403L NO20001403A NO20001403A NO20001403L NO 20001403 L NO20001403 L NO 20001403L NO 20001403 A NO20001403 A NO 20001403A NO 20001403 A NO20001403 A NO 20001403A NO 20001403 L NO20001403 L NO 20001403L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- substituted
- conr
- enantiomers
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9703378A SE9703378D0 (sv) | 1997-09-18 | 1997-09-18 | New compounds |
| PCT/SE1998/001604 WO1999014213A1 (en) | 1997-09-18 | 1998-09-09 | Substituted chroman derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20001403D0 NO20001403D0 (no) | 2000-03-17 |
| NO20001403L true NO20001403L (no) | 2000-05-18 |
Family
ID=20408298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20001403A NO20001403L (no) | 1997-09-18 | 2000-03-17 | Substituerte kromanderivater |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US6387899B1 (tr) |
| EP (1) | EP1025096B1 (tr) |
| JP (1) | JP4002392B2 (tr) |
| KR (1) | KR20010024078A (tr) |
| CN (1) | CN1278809A (tr) |
| AR (1) | AR016651A1 (tr) |
| AT (1) | ATE255099T1 (tr) |
| AU (1) | AU9193398A (tr) |
| BR (1) | BR9812239A (tr) |
| CA (1) | CA2303926A1 (tr) |
| DE (1) | DE69820103T2 (tr) |
| EE (1) | EE200000144A (tr) |
| HR (1) | HRP20000133A2 (tr) |
| HU (1) | HUP0100276A3 (tr) |
| IL (1) | IL135074A0 (tr) |
| IS (1) | IS5403A (tr) |
| NO (1) | NO20001403L (tr) |
| PL (1) | PL339661A1 (tr) |
| SE (1) | SE9703378D0 (tr) |
| SK (1) | SK2872000A3 (tr) |
| TR (1) | TR200000737T2 (tr) |
| WO (1) | WO1999014213A1 (tr) |
| ZA (1) | ZA987806B (tr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9703377D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| MXPA03006250A (es) | 2001-01-16 | 2003-09-22 | Astrazeneca Ab | Compuestos heterociclicos terapeuticos. |
| CN1592745A (zh) | 2001-01-16 | 2005-03-09 | 阿斯特拉曾尼卡有限公司 | 治疗用苯并－γ－吡喃酮化合物 |
| WO2002055014A2 (en) * | 2001-01-16 | 2002-07-18 | Astrazeneca Ab | Therapeutic chroman compounds |
| WO2002066454A1 (en) * | 2001-02-21 | 2002-08-29 | Sankyo Company, Limited | Chromene derivatives |
| ATE424825T1 (de) * | 2001-07-20 | 2009-03-15 | Psychogenics Inc | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten |
| GB0124020D0 (en) * | 2001-10-05 | 2001-11-28 | Astrazeneca Ab | Chemical compounds |
| ITTO20030140U1 (it) * | 2003-09-16 | 2005-03-17 | Interfila Srl | Matita cosmetica |
| CA2583087C (en) * | 2003-09-19 | 2012-07-10 | Galileo Pharmaceuticals, Inc. | Chroman derivatives |
| US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
| TWI346109B (en) * | 2004-04-30 | 2011-08-01 | Otsuka Pharma Co Ltd | 4-amino-5-cyanopyrimidine derivatives |
| KR100681453B1 (ko) * | 2005-03-22 | 2007-02-12 | 태남자동화기기 주식회사 | 권종 분류 기능을 구비한 지폐 방출기 |
| US9066903B2 (en) | 2006-02-28 | 2015-06-30 | The United States Of America As Represented By The Department Of Veterans Affairs | Pharmacological treatment of Parkinson's disease |
| WO2008130323A1 (en) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Novel 8-piperazine-tetrahydronaphtalene derivatives for the treatment of pain |
| WO2008130322A1 (en) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Novel 5-heterocyclyl-chromane derivatives for the treatment of pain |
| WO2008130319A2 (en) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain |
| WO2008130321A2 (en) * | 2007-04-23 | 2008-10-30 | Astrazeneca Ab | Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain |
| SA08290245B1 (ar) * | 2007-04-23 | 2012-02-12 | استرازينيكا ايه بي | مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0470176B1 (en) * | 1989-04-27 | 1993-12-29 | The Upjohn Company | Substituted 3-amino chromans |
| SE8904361D0 (sv) * | 1989-12-22 | 1989-12-22 | Astra Ab | New chroman and thiochroman derivatives |
| US5420151A (en) * | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
| US5972935A (en) * | 1995-08-11 | 1999-10-26 | Smithkline Beecham P.L.C. | Biphenyl(thio)amide and bipennylethan(thi) one derivatives, their preparation and their use as 5-HT1D receptor antagonists |
-
1997
- 1997-09-18 SE SE9703378A patent/SE9703378D0/xx unknown
-
1998
- 1998-08-27 ZA ZA987806A patent/ZA987806B/xx unknown
- 1998-09-09 JP JP2000511762A patent/JP4002392B2/ja not_active Expired - Fee Related
- 1998-09-09 SK SK287-2000A patent/SK2872000A3/sk unknown
- 1998-09-09 KR KR1020007002824A patent/KR20010024078A/ko not_active Application Discontinuation
- 1998-09-09 AT AT98944378T patent/ATE255099T1/de not_active IP Right Cessation
- 1998-09-09 EP EP98944378A patent/EP1025096B1/en not_active Expired - Lifetime
- 1998-09-09 BR BR9812239-8A patent/BR9812239A/pt not_active IP Right Cessation
- 1998-09-09 CN CN98811095A patent/CN1278809A/zh active Pending
- 1998-09-09 AU AU91933/98A patent/AU9193398A/en not_active Abandoned
- 1998-09-09 WO PCT/SE1998/001604 patent/WO1999014213A1/en active IP Right Grant
- 1998-09-09 DE DE69820103T patent/DE69820103T2/de not_active Expired - Fee Related
- 1998-09-09 IL IL13507498A patent/IL135074A0/xx unknown
- 1998-09-09 CA CA002303926A patent/CA2303926A1/en not_active Abandoned
- 1998-09-09 PL PL98339661A patent/PL339661A1/xx not_active Application Discontinuation
- 1998-09-09 US US09/171,572 patent/US6387899B1/en not_active Expired - Fee Related
- 1998-09-09 HU HU0100276A patent/HUP0100276A3/hu unknown
- 1998-09-09 EE EEP200000144A patent/EE200000144A/xx unknown
- 1998-09-09 TR TR2000/00737T patent/TR200000737T2/tr unknown
- 1998-09-17 AR ARP980104637A patent/AR016651A1/es not_active Application Discontinuation
-
2000
- 2000-03-09 HR HR20000133A patent/HRP20000133A2/hr not_active Application Discontinuation
- 2000-03-14 IS IS5403A patent/IS5403A/is unknown
- 2000-03-17 NO NO20001403A patent/NO20001403L/no not_active Application Discontinuation
- 2000-08-31 US US09/653,552 patent/US6384225B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO20001403D0 (no) | 2000-03-17 |
| CA2303926A1 (en) | 1999-03-25 |
| ZA987806B (en) | 1999-03-18 |
| SK2872000A3 (en) | 2000-11-07 |
| PL339661A1 (en) | 2001-01-02 |
| TR200000737T2 (tr) | 2000-09-21 |
| US6384225B1 (en) | 2002-05-07 |
| DE69820103D1 (de) | 2004-01-08 |
| EP1025096A1 (en) | 2000-08-09 |
| HRP20000133A2 (en) | 2001-12-31 |
| HUP0100276A2 (hu) | 2002-05-29 |
| BR9812239A (pt) | 2000-07-18 |
| AR016651A1 (es) | 2001-07-25 |
| EP1025096B1 (en) | 2003-11-26 |
| JP4002392B2 (ja) | 2007-10-31 |
| DE69820103T2 (de) | 2004-09-02 |
| US6387899B1 (en) | 2002-05-14 |
| ATE255099T1 (de) | 2003-12-15 |
| JP2001516755A (ja) | 2001-10-02 |
| IL135074A0 (en) | 2001-05-20 |
| KR20010024078A (ko) | 2001-03-26 |
| AU9193398A (en) | 1999-04-05 |
| WO1999014213A1 (en) | 1999-03-25 |
| EE200000144A (et) | 2001-02-15 |
| CN1278809A (zh) | 2001-01-03 |
| IS5403A (is) | 2000-03-14 |
| SE9703378D0 (sv) | 1997-09-18 |
| HUP0100276A3 (en) | 2002-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20001403L (no) | Substituerte kromanderivater | |
| SE9702799D0 (sv) | New compounds | |
| NO20001402L (no) | Substituerte kromanderivater | |
| NO20055316L (no) | Nye heterocykliske forbindelser som er nyttige ved behandling av inflammatoriske og allergiske forstyrrelser, fremgangsmate for fremstilling derav og farmasoytiske sammensetninger som inneholder slike | |
| HRP20070430T3 (en) | (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity | |
| CA2674548A1 (en) | Novel n-(2-aminophenyl) benzamide derivative having urea structure | |
| NO20061416L (no) | Pyrimidotiofenforbindelser | |
| ATE279406T1 (de) | Piperidinderivate mit tachykinin-antagonistischer wirkung | |
| AR049739A1 (es) | Derivados de aril-piridina | |
| YU40998A (sh) | Derivati supstituisanog 1,2,3,4-tetrahidronaftalina | |
| NO20061419L (no) | Triaza-spiropiperidinderivater for anvendelse som Glyt-1-inhibitorer i behandling av nevrologiske og nevropsykiatriske lidelser | |
| PE20010482A1 (es) | Derivados de 3-ureido-pirazol y procedimiento para su preparacion | |
| NO20072116L (no) | Farmasoytiske forbindelser | |
| CO5570669A2 (es) | Pirazolopirimidinas como agentes terapeuticos | |
| NO990551L (no) | Piperidin- og piperazinderivater, og deres anvendelse som muskarine antagonister | |
| NO20071198L (no) | N-(1H-indolyl)-1H-indol-2-karboksamidderivater, deres fremstilling og terapeutiske anvendelse | |
| RU2005113153A (ru) | Новые пиримидинамидные производные и их применение | |
| CO5720994A2 (es) | Derivados sustituidos del pirrol | |
| PE20030761A1 (es) | Derivados del 7-amino-benzotiazol | |
| SE0101579D0 (sv) | New compounds | |
| RU2008145597A (ru) | Гетероциклические арилсульфоны, пригодные для лечения расстройств, которые отвечают на модулирование 5-ht6 рецепторов | |
| CO5660263A2 (es) | Derivados de imidazol heteroaril sustituidos como antagonistas del receptor de glutamato | |
| PT1216245E (pt) | Derivados sulfonil-hidrazida farmaceuticamente activos | |
| AR041376A1 (es) | Piperazinas sustituidas por heterociclos para el tratamiento de la esquizofrenia | |
| EA200001009A1 (ru) | Производные пиридина, ингибирующие фосфодиэстеразу iv |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |